Search
for
Sort by
Research 451–480 of 1000+
- The Frequency of Alopecia and Quality of Life in High-School Students in Rural Areas (Sivrihisar, Mahmudiye, Alpu, Beylikova) of Eskisehir
- Assessment of selective elements in serum and hair samples of women with post-COVID-19 alopecia: copper significance
- Is Early-onset Androgenetic Alopecia Associated with Metabolic Syndrome? – A Descriptive Cross-sectional Study
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- The Lysosomal Protease Cathepsin L Is an Important Regulator of Keratinocyte and Melanocyte Differentiation During Hair Follicle Morphogenesis and Cycling
- New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature
- The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
- Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development
- Finasteride delays atherosclerosis progression in mice and is associated with a reduction in plasma cholesterol in men
- Endocrine Functions of the Testes
- The immune response to COVID‐19: Does sex matter?
- Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice
- P448: Identification of a novel RPS6KA3 variant in a female child with features of Coffin-Lowry syndrome: A case study
- Assessment of the efficacy of topical antiandrogen; spironolactone in patients with androgenetic alopecia by dermoscopy
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Transcriptome Analysis Reveals an Inhibitory Effect of Dihydrotestosterone-Treated 2D- and 3D-Cultured Dermal Papilla Cells on Hair Follicle Growth
- Cidea Control of Lipid Storage and Secretion in Mouse and Human Sebaceous Glands
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Saponins of Paris polyphylla for the Improvement of Acne: Anti-Inflammatory, Antibacterial, Antioxidant and Immunomodulatory Effects
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Observations that suggest a contribution of altered dermal papilla mitochondrial function to androgenetic alopecia
- The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
- Genetic Differences between Male and Female Pattern Hair Loss in a Korean Population
- Faculty Opinions recommendation of Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
- Association Between Androgenic Alopecia and Coronary Artery Disease: A Cross-Sectional Study of Han Chinese Male Population
- Sex steroid hormones are associated with mortality in COVID-19 patients
- Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats
- Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
- The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
- Utilising SNP Association Analysis as a Prospective Approach for Personalising Androgenetic Alopecia Treatment